EUVIMEDOpdag EUVIMED
ÜbersichtsarbeitOpen access

Understanding and countering opioid‐induced respiratory depression

Jordan T Bateman, Sandy E Saunders, Erica S Levitt

British Journal of Pharmacology · 2023-04 · 180 (7) · 813-828

DOI: 10.1111/bph.15580 ↗

At a glance

Übersichtsarbeit in British Journal of Pharmacology, published online on 2021-06-26. Written by Jordan T Bateman and 2 co-authors. Institution: Department of Pharmacology & Therapeutics, University of Florida, Gainesville, Florida, USA. Major MEDLINE topics: Opiate Overdose, Respiratory Insufficiency. Cited 139 times so far (Crossref); 153 references. The full text is freely available in PubMed Central. Funded by: NIDA NIH HHS, National Institutes of Health.

AbstractSubjectsBibliografiske oplysningerCiteRelated studies

Abstract (original language)

Respiratory depression is the proximal cause of death in opioid overdose, yet the mechanisms underlying this potentially fatal outcome are not well understood. The goal of this review is to provide a comprehensive understanding of the pharmacological mechanisms of opioid‐induced respiratory depression, which could lead to improved therapeutic options to counter opioid overdose, as well as other detrimental effects of opioids on breathing. The development of tolerance in the respiratory system is also discussed, as are differences in the degree of respiratory depression caused by various opioid agonists. Finally, potential future therapeutic agents aimed at reversing or avoiding opioid‐induced respiratory depression through non‐opioid receptor targets are in development and could provide certain advantages over naloxone. By providing an overview of mechanisms and effects of opioids in the respiratory network, this review will benefit future research on countering opioid‐induced respiratory depression. LINKED ARTICLES This article is part of a themed issue on Advances in Opioid Pharmacology at the Time of the Opioid Epidemic. To view the other articles in this section visit http://onlinelibrary.wiley.com/doi/10.1111/bph.v180.7/issuetoc

Subjects

MeSH terms (MEDLINE)

Opiate OverdoseRespiratory InsufficiencyHumansAnalgesics, OpioidNaloxoneRespiration

Author keywords

addictionbrainstemcontrol of breathingelectrophysiologymu opioid receptoropioidsrespiratory pharmacology

Substances

Analgesics, OpioidNaloxone

Authors and institutions

  • Department of Pharmacology & Therapeutics, University of Florida, Gainesville, Florida, USA.
  • Breathing Research and Therapeutics Center, University of Florida, Gainesville, Florida, USA.

Funding

  • NIDA NIH HHS
  • National Institutes of Health

Cite

APA

Bateman, J. T., Saunders, S. E., & Levitt, E. S. (2023). Understanding and countering opioid‐induced respiratory depression. British Journal of Pharmacology, 180(7), 813-828. https://doi.org/10.1111/bph.15580

Vancouver

Bateman JT, Saunders SE, Levitt ES. Understanding and countering opioid‐induced respiratory depression. British Journal of Pharmacology. 2023;180(7):813-828. doi:10.1111/bph.15580

BibTeX
@article{Bateman2023,
  author = {Bateman, Jordan T and Saunders, Sandy E and Levitt, Erica S},
  title = {Understanding and countering opioid‐induced respiratory depression},
  journal = {British Journal of Pharmacology},
  year = {2023},
  volume = {180},
  number = {7},
  pages = {813--828},
  doi = {10.1111/bph.15580}
}
Start for free →